Shuaishuai Xue
Guangzhou, 510515, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Activating ZBP1-centered PANoptosis and a collaborative innate-adaptive immune response sensitizes glioblastoma to PD-1 blockade.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: February 24, 2026
Overcoming blood-brain barrier and chemoresistance in glioblastoma by Angiopep-2-modified NK cell-derived extracellular vesicles for targeted delivery of temozolomide.
Journal: Journal of nanobiotechnology
Published: October 08, 2025
Efficacy and Safety of Neuromodulation Interventions for Autism Spectrum Disorders with Comorbidities: A Systematic Review.
Journal: Neuropsychiatric disease and treatment
Published: September 04, 2025
PCK2 as a potential therapeutic target for aggressive MYC-amplified non-WNT/non-SHH medulloblastoma based on tumor continuum.
Journal: Acta neuropathologica communications
Published: July 19, 2025
Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 09, 2024
Hypophysectomy, pituitary neuroadenolysis and pituitary radiosurgery for the treatment of refractory cancer pain: a historical review and mechanism investigation.
Journal: Frontiers in neurology
Published: November 18, 2024
A comprehensive analysis of the pyruvate kinase M1/2 (PKM) in human cancer.
Journal: Gene
Published: June 28, 2024
Nucleus accumbens shell electrical lesion attenuates seizures and gliosis in chronic temporal lobe epilepsy rats.
Journal: Epileptic disorders : international epilepsy journal with videotape
Published: June 10, 2024
Dysregulation of phosphoenolpyruvate carboxykinase in cancers: A comprehensive analysis.
Journal: Cellular signalling
Published: March 13, 2024
Lighting a Fire: Gasdermin-Mediated Pyroptosis Remodels the Glioma Microenvironment and Promotes Immune Checkpoint Blockade Response.
Journal: Frontiers in immunology
Published: April 01, 2022
A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma.
Journal: Frontiers in cell and developmental biology
Published: November 10, 2021
Last Updated: 09/26/2026